NCT05043922 2026-01-30
A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma
Haihe Biopharma Co., Ltd.
Phase 2 Active not recruiting
Haihe Biopharma Co., Ltd.
Haihe Biopharma Co., Ltd.
Haihe Biopharma Co., Ltd.
Haihe Biopharma Co., Ltd.